Anthony Gamboa of Vanderbilt University Medical Center (United States) presented on early detection and intervention strategies for esophageal cancer, focusing on Barrett’s esophagus as a precancerous condition. He discussed screening methods including endoscopy protocols and newer non-endoscopic technologies, as well as treatment options for dysplastic Barrett’s using radiofrequency ablation and cryotherapy. The presentation covered endoscopic therapy options for early esophageal cancer, comparing endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD), with ESD generally recommended for larger lesions.

This presentation was delivered as part of the webinar on Esophageal Cancer in 2026 hosted by Dr. Dan Patel of Vanderbilt University Medical Center, United States.

11views

You may also like

Oligometastatic disease for esophageal squamous cell carcinoma – Motoo Nomura, Kyoto University Hospital, Japan
ISDE Members Only
0views
0likes
Listen to Dr. Motoo Nomura present during the Young ISDE Committee’s 3rd Annual Shark’s Tank for young researchers. Known as the Dragon’s Den in the northern hemisphere, the Shark’s Tank session includes presentations from early-career ...
Indocyanine Green Dye as Surgeon’s Intraoperative Armamentarium for Assessing Gastric Conduit Perfusion – Mohit Malhotra
ISDE Members Only
1views
0likes
As we know, post-esophagectomy anastomotic complications (5-20%) are feared, and poor perfusion is a surgically modifiable factor. However, a suitable, noninvasive, conveniently accessible, cost-effective, objective, and reproducible approach to ...
Endoscopic Management of GERD: Controversies in GERD Part 2 with Haruhiro Inoue
11views
0likes
Gastroesophageal Reflux Disease (GERD) is the most prevalent esophageal disease. It is a condition affecting up to 20% of the western world and has a significant negative impact in the patient’s quality of life. The typical symptoms are ...
Role of Anti-Reflux Procedures in Barrett’s Esophagus Management – John Hunter
ISDE Members Only
2views
0likes
Listen to Dr. John Hunter present during the State of the Art Management of Barrett’s Esophagus Session, held during the 2025 ISDE World Congress in Brisbane, Australia, from September 18-20, 2025. Watch all presentations in this session, ...
Locally Advanced Esophageal Cancer - Beyond Clinical Trials
ISDE Members Only
1views
0likes
Locally advanced esophageal cancer, particularly adenocarcinoma, is increasingly diagnosed in patients under 50, with a notable rise in cases among black and Hispanic individuals. The session discusses treatment challenges, survival outcomes, ...
Neoadjuvant chemoradiotherapy vs. perioperative chemotherapy for gastro-esophageal cancer - an international multidisciplinary Delphi consensus study, Hidde Overtoom, Amsterdam UMC, Netherlands
ISDE Members Only
0views
0likes
Listen to Dr. Hidde Overtoom present during the Young ISDE Committee’s 3rd Annual Shark’s Tank for young researchers. Known as the Dragon’s Den in the northern hemisphere, the Shark’s Tank session includes presentations from early-career ...
Decreasing Morbidity in Video Assisted Esophagectomy with Indocyanine Green Guided Thoracic Duct Delineation – Abhijit Talukdar
ISDE Members Only
1views
0likes
This video demonstrates decreasing morbidity in video assisted esophagectomy with indocyanine green guided thoracic duct delineation. I am presently working as Professor and Head of the department Surgical Oncology at Dr B Borooah Cancer ...
Long Term PPI Therapy: Controversies in GERD Part 1 with Kerry Dunbar
15views
0likes
Gastroesophageal Reflux Disease (GERD) is the most prevalent esophageal disease. It is a condition affecting up to 20% of the western world and has a significant negative impact in the patient’s quality of life. The typical symptoms are ...
Treatment of T1 Cancer Associated with Barrett's Esophagus - Endoscopic Resection Should Be Done – Michael Bourke
ISDE Members Only
1views
0likes
Listen to Dr. Michael Bourke present during the Esophageal Debates Session, held during the 2025 ISDE World Congress in Brisbane, Australia, from September 18-20, 2025. Watch all presentations in this session, including: Treatment of T1 Cancer ...
Page 4 of 9